SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending sharply upwards following exceptionally positive Phase 2 S-OLARIS trial data for sonelokimab in axial spondyloarthritis, which revealed "disease-modifying" potential and robust efficacy. The community is buzzing with expectations for significant upside, fueled by a major institutional buyback, strong financials, and the upcoming Investor Day, intensifying talks of a potential short squeeze and a "best-in-class" valuation.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is sparking intense debate following its earnings report, where the company announced a beta mortgage product and projected adjusted EBITDA profitability by Q2, electrifying bulls confident in its AI and capital-light transformation while bears remain skeptical of persistent losses and the iBuying model's viability amidst market volatility.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid fresh market uncertainty as new global tariffs announced by Trump following a Supreme Court ruling are sparking concerns over potential trade friction with allies like the EU and India. This sentiment is amplified by a significant pullback in Bitcoin, which some in the community see as a broader signal of financial system stress, with many actively debating whether the market will recover or face a deeper correction ahead of NVIDIA's crucial earnings report this week.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is trending as the crypto community actively buys perceived dips, fueled by strong HODLing sentiment and anticipation of a broader meme coin season. Many are discussing "loading the boat" and awaiting a significant price run, often using the "feels good man" meme.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is currently gaining significant attention due to a recent pivotal update regarding its tokenomics and platform development. The community is actively discussing the confirmed end of token inflation with no more SNX to be minted, coupled with the upcoming implementation of buybacks coinciding with the launch of Perps v3. This fundamental shift towards a deflationary model and enhanced platform utility, alongside a recent high-profile trading competition with a $1 million prize, is fueling strong bullish sentiment and driving conversation among traders about its potential for growth.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is seeing significant attention after reporting blowout earnings, strong guidance, and an ambitious capital expenditure outlook that reaffirms its central role in the AI supercycle, with investors also closely monitoring ongoing U.S.-Taiwan trade discussions that could further impact global chip supply.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to accelerating hyperscale orders for its 800G transceivers, notably from Amazon, alongside plans to significantly expand its AI data center manufacturing. The community is buzzing about potential short squeezes and higher price targets as the optical components sector plays a crucial role in AI infrastructure buildouts.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is drawing attention following reports of significant ETF inflows and its strategic shift to scale traditional finance on-chain. The community is sharply divided, with proponents advocating to buy dips and stake amid regulatory optimism, while skeptics foresee further downside for the asset.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to a recent filing that would allow Trump's trust to sell a significant amount of stock and includes an evergreen provision for future share issuance, sparking active community discussion and widespread concerns over potential dilution and the company's long-term valuation.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as its Bysanti drug received FDA approval for bipolar I disorder and schizophrenia, notably gaining New Chemical Entity status and patent protection until 2044. The community is now keenly discussing the potential for a significant valuation re-rating, a short squeeze, and strong buyout interest from major pharma due to this and its promising GLP-1 nausea pipeline candidate.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.

KRBP
Kiromic BioPharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest KRBP News

KRBPKiromic BioPharma Inc